Press Releases

Apr 04, 2022
Company’s ultra-sensitive biomarker technology supports milestone achievement in establishing a method for clinicians to identify and interpret elevated values of sNfL in individual patients BILLERICA, Mass. --(BUSINESS WIRE)--Apr. 4, 2022-- Quanterix Corporation (NASDAQ: QTRX), a company
Mar 09, 2022
BILLERICA, Mass. --(BUSINESS WIRE)--Mar. 9, 2022-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that its Chairman and Chief Executive Officer, Kevin Hrusovsky will present in-person at the
Mar 01, 2022
Masoud Toloue , President of Quanterix and Diagnostics, to Become CEO and Join Board of Directors Kevin Hrusovsky , Chairman and CEO of Quanterix , to Assume Role as Executive Chairman of the Board Moves are Designed to Propel the Precision Health Vision and Catalyze the Next Chapter of Growth and
Feb 28, 2022
Multiple category wins, voted on by Quanterix’ employees, highlight company’s commitment to establishing an inclusive company culture, competitive compensation BILLERICA, Mass. --(BUSINESS WIRE)--Feb. 28, 2022-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the
Feb 09, 2022
BILLERICA, Mass. --(BUSINESS WIRE)--Feb. 9, 2022-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that its Chairman and Chief Executive Officer, Kevin Hrusovsky , will present virtually at the
Displaying 11 - 20 of 24